tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dane Leone, 125 are a BUY (81.7%), 26 are a HOLD (16.99%), 2 are a SELL (1.31%).
Analyst Dane Leone, carries an average stock price target met ratio of 52.46% that have a potential upside of 35.1% achieved within 212 days. Previously, Dane Leone worked at RAYMOND JAMES, BTIG.
Dane Leone’s has documented 275 price targets and ratings displayed on 39 stocks. The coverage was on Healthcare, Technology, Energy, Consumer Cyclical sectors.
Most recent stock forecast was given on RLAY, Relay Therapeutics at 19-May-2026.
Analyst best performing recommendations are on NKTX (NKARTA).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) at 12/27/2021. The price target of $17 was fulfilled within 7 days with a profit of $5.62 (49.38%) receiving and performance score of 70.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
10 months 25 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
11 months 13 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
11 months 14 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 1 months 29 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 4 months 27 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
Which stock is Dane Leone most bullish on?
